SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950116-01-500264
Filing Date
2001-05-22
Accepted
2001-05-22 00:00:00
Documents
1
Period of Report
2001-05-21
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 P311766.TXT p311766.txt 8-K 4894
  Complete submission text file 0000950116-01-500264.txt   6373
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 1645751
SIC: 2834 Pharmaceutical Preparations